Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes

R. A. De Fronzo, C. F. Burant, P. Fleck, C. Wilson, Q. Mekki, R. E. Pratley

Producción científica: Article › revisión exhaustiva

89 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes'. En conjunto forman una huella única.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology